NCT06030895 2024-03-12
Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.
Damanhour University
Phase NA Completed
Clinical Trials
14 trialsNCT02072486 2022-07-25
Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase NA Completed
NCT05391867 2022-05-26
Assessment of the Efficacy of Lenvatinib Versus Sorafenib in the Management of Advanced Hepatocellular Carcinoma
Sir Salimullah Medical College Mitford Hospital
Phase NA Unknown
NCT05121571 2021-11-26
The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study
Sun Yat-sen University
Phase NA Completed
NCT01141478 2021-10-15
HCC
Loma Linda University
Phase NA Terminated
NCT03140332 2020-07-20
HCC-CTPerf
Centre Hospitalier Universitaire, Amiens
Phase NA Completed
NCT02259647 2019-10-28
Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India
Phase NA Completed
NCT02529761 2019-08-01
TACE With or Without Sorafenib in Intermediate Stage Hepatocellular Carcinoma
Air Force Military Medical University, China
Phase NA Unknown
NCT02748304 2019-02-15
Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma
Fudan University
Phase NA Terminated
NCT03730675 2018-12-21
Irradiation Stent Placement Plus TACE for HCC and PVTT
Zhongda Hospital
Phase NA Unknown
NCT01005875 2017-05-10
RAD 0901
University of Alabama at Birmingham
Phase NA Terminated
NCT02013089 2016-08-30
GITIC
Sun Yat-sen University
Phase NA Unknown
NCT02537158 2016-03-15
Sorafenib and TACE as Adjuvant Therapy for MVI in HCC Patients After Radical Resection
ChineseAMS
Phase NA Unknown
NCT00619242 2014-03-12
Barrett's
University of Chicago
Phase NA Terminated